H-1B sponsorship profile: Rocket Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, Rocket Pharmaceuticals, Inc filed 6 Labor Condition Applications covering 6 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (6 certified of 6 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Rocket Pharmaceuticals, Inc’s H-1B petitions range from $136,000 at the low end to $193,640 at the high end, with a petition-weighted average of $158,293. That range reflects the mix of occupations the company sponsors, led by Senior Scientist, Process Development - Upstream (2 petitions at $136,000 avg), followed by Validation Engineer III and Senior Project Manager, CMC. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Rocket Pharmaceuticals, Inc is headquartered in Cranbury, NJ under NAICS code 54171, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Rocket Pharmaceuticals, Inc ranks. By H-1B petition volume, Rocket Pharmaceuticals, Inc is #23,486 of 119,880 employers nationally and #1,770 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.